MAUI Imaging, inventor of patented technology that sees anatomy other ultrasounds cannot, today emerged from stealth with the announcement of a $4 million U.S. Department of Defense (US Army Medical Research and Development Command) contract to support trauma medicine across four branches of the military seeking to enable faster diagnosis and interventional care in high volume (mass casualty) and/or resource limited environments.
“With the U.S. military contract and our technology becoming more visible on a broader stage, we’ve decided it’s time to come out of stealth and show what we have been working on,” said MAUI Imaging CEO and co-founder David Specht. “The feedback we have received from physicians and technologists highlights the profound need for a new ultrasound-based technology that enables imaging of all types of tissues. That need is most pronounced in trauma medicine, which is a major focus of MAUI’s collaborative development efforts. Going forward, MAUI will be able to supply the volumetric imaging data for AI tools that predominantly come from CT and MRI.”
MAUI will present a poster describing their breakthrough imaging technology and its potential use in trauma diagnosis and triage at the Military Health System Research Symposium taking place August 26-29, 2024 in Florida. MAUI’s Chief Medical Officer, John Cheronis, MD PhD will present imaging data from the initial studies funded by the MRDC. Additional imaging of trauma pathology is being developed in partnership with Dr. Rosemary Kozar, MD PhD from the University of Maryland Shock Trauma Center and Dr. Matt Bradley, CAPT USN, Uniform Services University of the Health Sciences, a part of the Walter Reed National Military Medical Center, as part of the USAMRDC project.
